Please provide your email address to receive an email when new articles are posted on . Rademikibart improved lung function and asthma control in adults with moderate to severe persistent asthma. The ...

The global trial met its primary endpoint showing both doses of rademikibart treatment significantly improved lung function at Week 12 The significant improvement in lung function was observed as ...

In many patients, annual short-acting beta2-agonist prescription fulfillment is indicative of uncontrolled disease and increased incidence of exacerbations. Credit: Getty Images. Short-acting beta ...

Please provide your email address to receive an email when new articles are posted on . 42.6% of patients filled a SABA prescription 30 days before an exacerbation, and 61.4% did so within 30 days ...

Older adults with coexisting asthma and chronic obstructive pulmonary disease (COPD), known as asthma-COPD overlap, who take fixed-dose combinations of inhaled corticosteroids and long-acting β ...

High-intensity interval training (HIIT) also improved quality of life and physical activity levels while reducing anxiety and depression levels. High-intensity interval training (HIIT) is an effective ...

(CNN) — The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.

(MENAFN- Market Press Release) December 13, 2025 7:27 am - The Dupixent market for moderate-to-severe asthma is valued at $3.25 billion in 2025 and is projected to grow at a 14% CAGR through 2032.